Perosphere Technologies Set to Present at International Symposium
Perosphere Technologies Inc., a leading company in medical technology, is excited to announce its participation in an important event centered around critical and point-of-care testing. The organization will present its findings at the 29th ADLM International Critical & Point of Care Testing (CPOCT) Symposium. This gathering is a prime opportunity to explore innovations in the medical field and discuss advancements in diagnostic technologies.
Presentation Insights from CEO Dr. Sasha Bakhru
At the symposium, CEO Dr. Sasha Bakhru will give an oral presentation that highlights the groundbreaking features of the Perosphere ClotChek™ coagulometer. Dr. Bakhru will focus on the accuracy of Whole Blood Clotting Time (WBCT) assessments in patients taking direct oral anticoagulants (DOACs). This distinction is especially important as it contrasts anticoagulated patients with those who are not on medication.
“We thank the ADLM for hosting this event, which showcases the latest advancements in critical testing,” remarked Dr. Bakhru. His insights will emphasize how the Perosphere ClotChek™ plays a crucial role for patients on DOACs, who are at a heightened risk for bleeding complications.
Details on the Oral Presentation and Posters
Dr. Bakhru, well-respected in his field, will present data from a key study demonstrating how responsive the Perosphere ClotChek is to different anticoagulation levels in whole blood samples. His findings will clearly outline the differences between peak and minimal anticoagulation levels and illustrate how ClotChek results align with those from healthy subjects.
Oral Presentation Details
Title: Clinical Performance of a Novel Point-of-Care Coagulometer for the DOACs
Presenter: Sasha Bakhru, PhD, CEO, Perosphere
Date: September 26, 2024
Time: 3:15 - 3:30 pm
Scientific Posters Showcasing Innovative Solutions
In addition to Dr. Bakhru's oral presentation, Perosphere will also display two posters among the 32 showcased at the symposium. These posters will delve into the performance of the coagulometer with a focus on accuracy, linearity, and precision when using venous whole blood samples along with quality controls.
Poster Presentation Specifics
Title: Accuracy and Precision Evaluation of a Novel Point-of-Care Coagulometer for the DOACs
Author: Dardan Osmani, MS, MBA, Director of Technical Operations, Perosphere
How Perosphere ClotChek Affects Patient Care
The information shared at the symposium will highlight the Perosphere ClotChek's innovative approach to coagulation diagnostics. This state-of-the-art device provides rapid WBCT results within 3-8 minutes, using just one drop of fresh whole blood from a venous sample. Such accessibility has the potential to greatly enhance patient management, especially for individuals receiving anticoagulant treatments.
About Perosphere Technologies
Perosphere Technologies is dedicated to transforming diagnostic practices at the point of care in both hospitals and outpatient clinics. The company aims to bring its flagship product, the Perosphere ClotChek™, to market. This coagulometer is crafted to deliver immediate and accurate diagnostic information that aids clinicians in making informed treatment decisions for patients vulnerable to bleeding.
By prioritizing the improvement of care standards for patients undergoing anticoagulation therapy, Perosphere ClotChek™ seeks to boost efficiency, reduce costs, and significantly enhance patient outcomes.
Contact Information
For more information about Perosphere Technologies or its products, interested individuals can get in touch via email or phone. Please contact the company for any inquiries.
Frequently Asked Questions
What is Perosphere Technologies focused on?
Perosphere Technologies is dedicated to developing advanced coagulation diagnostics to enhance patient care and treatment decisions.
What is the Perosphere ClotChek™?
The Perosphere ClotChek™ is a novel point-of-care coagulometer designed to rapidly and accurately measure whole blood clotting times.
When will Perosphere present its findings?
The company will present its findings at the 29th ADLM CPOCT Symposium, taking place between September 25-27, 2024.
Who will be presenting on behalf of Perosphere?
Dr. Sasha Bakhru, the CEO of Perosphere, will lead the oral presentation, highlighting the device's capabilities.
What can attendees expect from the presentations?
Attendees can look forward to insights into the effectiveness and precision of the Perosphere ClotChek in measuring WBCT for patients utilizing DOACs.
